Loading chat...

OH SB227

Bill

Status

Introduced

7/1/2025

Primary Sponsor

Hearcel Craig

Click for details

Origin

Senate

136th General Assembly

AI Summary

  • Caps patient cost sharing for prescription insulin at $35 per 30-day supply, regardless of the amount or type of insulin prescribed

  • Applies to all health benefit plans amended, issued, or renewed on or after the bill's effective date

  • Defines "prescription insulin drug" as any prescription drug containing insulin used to treat diabetes

  • Cost sharing is charged on a per-prescription-fill basis

  • Overrides existing Ohio Revised Code section 3901.71 to implement this cap on health plan issuers

Legislative Description

Cap cost sharing for prescription insulin drugs

Health and Human Services : Public Health

Last Action

Referred to committee: Financial Institutions, Insurance and Technology

10/1/2025

Committee Referrals

Financial Institutions, Insurance and Technology10/1/2025

Full Bill Text

No bill text available